A once-daily oral GLP-1 conferred greater reductions in HbA1c and body weight than placebo among adults with type 2 diabetes, ...

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

Key Takeaways Orforglipron becomes first oral GLP-1 receptor agonist to complete Phase 3 trial: Eli Lilly’s once-daily pill ...

Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron in lowering blood sugar and promoting weight loss, ...

Wellness startups are launching products that target the natural growth of GLP-1, the hormone that medicines like Ozempic and ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The results bring Eli Lilly’s pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...

New research suggests omega-3 may kill two birds with one stone by preventing two common and debilitating diseases ...

Learn the best times to take apple cider vinegar to enhance its health benefits, including weight loss and improved digestion ...

Nampa, April 15, 2025 (GLOBE NEWSWIRE) -- Best Diabetes Supplement of 2025: Learn How GlucoRedi Sets a New Benchmark in Wellness Industry Content Promoted By Branding EX Solution pvt ltd ( ...